Mutual funds holding both Aurobindo Pharma and Gujarat Themis Biosyn

Comparing mutual fund co-ownership helps identify hidden asset concentration. Our reverse lookup database shows that 3 mutual funds hold active equity positions in both Aurobindo Pharma and Gujarat Themis Biosyn. The scheme with the highest combined exposure is quant Manufacturing Fund (Quant MF), which holds a 9.86% stake in Aurobindo Pharma and a 5.70% stake in Gujarat Themis Biosyn, amounting to a combined conviction weight of 15.56%.

When multiple mutual funds in your portfolio double-up on the same stock pairs, it limits your diversification benefits. If you also hold either of these companies directly in your demat account, your aggregate exposure is amplified. This co-ownership pattern is standard among index-tracking products but represents active, concentrated strategies in equity schemes.